Skip to content

Editorial Board

Editorial Board

The EXEC 369 phase4-60f40478-20260901-diag Journal editorial team oversees peer review, research quality, ethics, and transparency, with role, affiliation, country, and profile details where available.

0 researchersDouble-blind peer review

Editorial board details are not published yet

The editorial board for EXEC 369 phase4-60f40478-20260901-diag Journal will appear here once its members are confirmed.

Board Transparency

The public board record lists role, affiliation, country, and Scholardemia profile, ORCID, or Google Scholar links where available.

Board members must consent to serve before they are listed publicly. The board list is reviewed at least annually; the current policy review date is 25 August 2025.

Editors and board members do not receive privileged publication treatment. Submissions from editors, editorial board members, guest editors, or individuals with a close relationship to the journal are handled by an independent editor with no conflict of interest.